Dr. Pan Yuanhang

Dr. Pan Yuanhang, born in 1985, holds a Bachelor’s degree in Chemistry from Zhejiang University and a PhD in Chemistry from the National University of Singapore. With a strong academic background, he has published more than 20 high-impact papers in leading international journals such as J. Am. Chem. Soc., Angew. Chem. Int. Ed., Green Chem., Adv. Synth., and Chem. Eur. J. Dr. Pan is currently the R&D Director at Biosensors International, the world’s fourth-largest coronary stent company.
With over a decade of R&D experience in the pharmaceutical and medical device industries, Dr. Pan specializes in new product development, organic synthesis, technology transfer, analytical testing development, and sterilization technologies. He has led or contributed to the full lifecycle development of multiple Class III drug-device combination products, from early-stage research to CE certification and successful market launch. Additionally, Dr. Pan is the inventor of China’s first limus drug-coated balloon, leading the team to secure approval from the NMPA and successfully bring the product to market, making significant contributions to the advancement of the medical device sector in China.

潘远航博士，浙江大学化学学士，新加坡国立大学化学博士，拥有深厚的学术背景，已在国际顶尖期刊上发表了20余篇高水平论文，涵盖《J. Am. Chem. Soc.》《Angew. Chem. Int. Ed.》《Green Chem.》《Adv. Synth.》《Chem. Eur. J.》等。潘博士现任全球第四大心脏支架公司——柏盛集团研发总监。
潘博士在制药与医疗器械行业积累了十余年的研发经验，擅长新产品开发、有机合成、技术转移、分析测试开发以及行业灭菌技术。他主导或参与了多个三类药械组合产品的全流程开发，从早期研发到获得CE认证并成功上市，均取得了重要成果。此外，潘博士还是中国首款莫司类药物球囊的发明人，带领团队推动该产品成功获得国家药监局批准并顺利上市，为中国药械领域的发展做出了突出贡献。